Ann Rheum Dis 68:310-317 doi:10.1136/ard.2008.088096
  • Recommendations

EULAR recommendations for the management of primary small and medium vessel vasculitis

  1. C Mukhtyar1,
  2. L Guillevin2,
  3. M C Cid3,
  4. B Dasgupta4,
  5. K de Groot5,
  6. W Gross6,
  7. T Hauser7,
  8. B Hellmich8,
  9. D Jayne9,
  10. C G M Kallenberg10,
  11. P A Merkel11,
  12. H Raspe6,
  13. C Salvarani12,
  14. D G I Scott13,
  15. C Stegeman10,
  16. R Watts14,
  17. K Westman15,
  18. J Witter16,
  19. H Yazici17,
  20. R Luqmani1,
  21. for the European Vasculitis Study Group
  1. 1
    University of Oxford, Oxford, UK
  2. 2
    University of Paris Descartes, Paris, France
  3. 3
    Hospital Clinic, Barcelona, Spain
  4. 4
    Southend University Hospital NHS Foundation Trust, Westcliff-on-Sea, UK
  5. 5
    Klinikum Offenbach, Offenbach, Germany
  6. 6
    University Hospital of Schleswig-Holstein, Lübeck, Germany
  7. 7
    University Hospital, Zurich, Switzerland
  8. 8
    Kreiskrankenhaus Plochingen, Plochingen, Germany
  9. 9
    Addenbrooke’s Hospital, Cambridge, UK
  10. 10
    University Medical Centre Groningen, Groningen, The Netherlands
  11. 11
    Boston University School of Medicine, Boston, Massachusetts, USA
  12. 12
    Arcispedale S Maria Nuova, Reggio Emilia, Italy
  13. 13
    Norfolk and Norwich University Hospital Trust, Norwich, UK
  14. 14
    Ipswich Hospital NHS Trust, Ipswich, UK
  15. 15
    Malmo University Hospital, Malmo, Sweden
  16. 16
    US Food and Drug Administration, Rockville, Maryland, USA
  17. 17
    University of Istanbul, Istanbul, Turkey
  1. R Luqmani, Nuffield Orthopaedic Centre, University of Oxford, Windmill Road, Oxford OX3 7LD, UK; raashid.luqmani{at}
  • Accepted 7 April 2008
  • Published Online First 15 April 2008


Objectives: To develop European League Against Rheumatism (EULAR) recommendations for the management of small and medium vessel vasculitis.

Methods: An expert group (consisting of 10 rheumatologists, 3 nephrologists, 2 immunologists, 2 internists representing 8 European countries and the USA, a clinical epidemiologist and a representative from a drug regulatory agency) identified 10 topics for a systematic literature search using a modified Delphi technique. In accordance with standardised EULAR operating procedures, recommendations were derived for the management of small and medium vessel vasculitis. In the absence of evidence, recommendations were formulated on the basis of a consensus opinion.

Results: In all, 15 recommendations were made for the management of small and medium vessel vasculitis. The strength of recommendations was restricted by low quality of evidence and by EULAR standardised operating procedures.

Conclusions: On the basis of evidence and expert consensus, recommendations have been made for the evaluation, investigation, treatment and monitoring of patients with small and medium vessel vasculitis for use in everyday clinical practice.


  • Competing interests: None declared.

Free sample This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of ARD.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article